Stockbauer, Anna
Beyer, Leonie
Huber, Maria
Kreuzer, Annika
Palleis, Carla
Katzdobler, Sabrina
Rauchmann, Boris-Stephan
Morbelli, Silvia
Chincarini, Andrea
Bruffaerts, Rose
Vandenberghe, Rik
Kramberger, Milica G.
Trost, Maja
Garibotto, Valentina
Nicastro, Nicolas
Lathuilière, Aurélien
Lemstra, Afina W.
van Berckel, Bart N. M.
Pilotto, Andrea
Padovani, Alessandro
Ochoa-Figueroa, Miguel A.
Davidsson, Anette
Camacho, Valle
Peira, Enrico
Bauckneht, Matteo
Pardini, Matteo
Sambuceti, Gianmario
Aarsland, Dag
Nobili, Flavio
Gross, Mattes
Vöglein, Jonathan
Perneczky, Robert
Pogarell, Oliver
Buerger, Katharina
Franzmeier, Nicolai
Danek, Adrian
Levin, Johannes
Höglinger, Günter U.
Bartenstein, Peter
Cumming, Paul
Rominger, Axel
Brendel, Matthias http://orcid.org/0000-0002-9247-2843
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (EXC 2145 SyNergy – ID 390857198)
Universitätsklinik München
Article History
Received: 9 March 2023
Accepted: 26 October 2023
First Online: 16 November 2023
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (LMU Munich—application numbers 17-569 and 399-09) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed written consent was obtained from all patients.
: L.B. is an Novartis Radiopharmaceuticals GmbH employee, unrelated to this work. M.B. received speaker honoraria from GE healthcare, Roche and LMI and is an advisor of LMI. OP received speaker fees from Lundbeck, Otsuka, Takeda and Janssen. R.P. has received honoraria for advisory boards and speaker engagements from Roche, EISAI, Eli Lilly, Biogen, Janssen-Cilag, Astra Zeneca, Schwabe, Grifols, Novo Nordisk and Tabuk. VG received financial support for research and/or speaker fees through her institution from Siemens Healthineers, GE Healthcare and Novo Nordisk.